Suppr超能文献

TGR5:体重维持和葡萄糖代谢的新靶点。

TGR5: a novel target for weight maintenance and glucose metabolism.

作者信息

Chen Xiaosong, Lou Guiyu, Meng Zhipeng, Huang Wendong

机构信息

Division of Gene Regulation and Drug Discovery, Beckman Research Institute, City of Hope National Medical Center, 1500 East Duarte Road, Duarte, CA 91010, USA.

出版信息

Exp Diabetes Res. 2011;2011:853501. doi: 10.1155/2011/853501. Epub 2011 Jun 21.

Abstract

TGR5, an emerging G protein-coupled receptor, was identified as a membrane receptor for bile acids. The expression of TGR5 and its function are distinct from the previously identified nuclear bile acid receptor, farnesoid X receptor (FXR). These two bile acid receptors complement with each other for maintaining bile acid homeostasis and mediating bile acid signaling. Both receptors are also shown to play roles in regulating inflammation and glucose metabolism. An interesting finding for TGR5 is its role in energy metabolism. The discovery of TGR5 expression in brown adipocyte tissues (BATs) and the recent demonstration of BAT in adult human body suggest a potential approach to combat obesity by targeting TGR5 to increase thermogenesis. We summarize here the latest finding of TGR5 research, especially its role in energy metabolism and glucose homeostasis.

摘要

TGR5是一种新发现的G蛋白偶联受体,被确定为胆汁酸的膜受体。TGR5的表达及其功能与先前鉴定的核胆汁酸受体法尼醇X受体(FXR)不同。这两种胆汁酸受体相互补充,以维持胆汁酸稳态并介导胆汁酸信号传导。这两种受体还显示在调节炎症和葡萄糖代谢中发挥作用。TGR5的一个有趣发现是其在能量代谢中的作用。在棕色脂肪组织(BATs)中发现TGR5表达,以及最近在成人体内发现BAT,提示了一种通过靶向TGR5以增加产热来对抗肥胖的潜在方法。我们在此总结TGR5研究的最新发现,特别是其在能量代谢和葡萄糖稳态中的作用。

相似文献

1
TGR5: a novel target for weight maintenance and glucose metabolism.
Exp Diabetes Res. 2011;2011:853501. doi: 10.1155/2011/853501. Epub 2011 Jun 21.
2
Farnesoid X receptor induces Takeda G-protein receptor 5 cross-talk to regulate bile acid synthesis and hepatic metabolism.
J Biol Chem. 2017 Jun 30;292(26):11055-11069. doi: 10.1074/jbc.M117.784322. Epub 2017 May 6.
3
TGR5: an emerging bile acid G-protein-coupled receptor target for the potential treatment of metabolic disorders.
Drug Discov Today. 2009 May;14(9-10):523-30. doi: 10.1016/j.drudis.2009.02.005. Epub 2009 Feb 25.
5
Bile acids as regulators of hepatic lipid and glucose metabolism.
Dig Dis. 2010;28(1):220-4. doi: 10.1159/000282091. Epub 2010 May 7.
6
Gluco-Metabolic Effects of Pharmacotherapy-Induced Modulation of Bile Acid Physiology.
J Clin Endocrinol Metab. 2020 Jan 1;105(1). doi: 10.1210/clinem/dgz025.
7
Bile acid receptors in non-alcoholic fatty liver disease.
Biochem Pharmacol. 2013 Dec 1;86(11):1517-24. doi: 10.1016/j.bcp.2013.08.015. Epub 2013 Aug 26.
8
Clinical relevance of the bile acid receptor TGR5 in metabolism.
Lancet Diabetes Endocrinol. 2017 Mar;5(3):224-233. doi: 10.1016/S2213-8587(16)30155-3. Epub 2016 Sep 14.
9
Bile-acid-activated receptors: targeting TGR5 and farnesoid-X-receptor in lipid and glucose disorders.
Trends Pharmacol Sci. 2009 Nov;30(11):570-80. doi: 10.1016/j.tips.2009.08.001. Epub 2009 Sep 14.
10
Role of bile acid receptor FXR in development and function of brown adipose tissue.
Biochim Biophys Acta Mol Cell Biol Lipids. 2023 Feb;1868(2):159257. doi: 10.1016/j.bbalip.2022.159257. Epub 2022 Nov 17.

引用本文的文献

1
Unraveling the gut microbiota's role in obesity: key metabolites, microbial species, and therapeutic insights.
J Bacteriol. 2025 May 22;207(5):e0047924. doi: 10.1128/jb.00479-24. Epub 2025 Apr 4.
4
Post sleeve gastrectomy-enriched gut commensal Clostridia promotes secondary bile acid increase and weight loss.
Gut Microbes. 2025 Dec;17(1):2462261. doi: 10.1080/19490976.2025.2462261. Epub 2025 Feb 6.
5
NLRP3 Inflammasome and Gut Dysbiosis Linking Diabetes Mellitus and Inflammatory Bowel Disease.
Arch Intern Med Res. 2024;7(3):200-218. doi: 10.26502/aimr.0178. Epub 2024 Aug 31.
6
The energy metabolism-promoting effect of aconite is associated with gut microbiota and bile acid receptor TGR5-UCP1 signaling.
Front Pharmacol. 2024 Sep 11;15:1392385. doi: 10.3389/fphar.2024.1392385. eCollection 2024.
7
Intestinal Stearoyl-CoA Desaturase-1 Regulates Energy Balance via Alterations in Bile Acid Homeostasis.
Cell Mol Gastroenterol Hepatol. 2024;18(6):101403. doi: 10.1016/j.jcmgh.2024.101403. Epub 2024 Sep 14.
9
Gut microbiota in overweight and obesity: crosstalk with adipose tissue.
Nat Rev Gastroenterol Hepatol. 2024 Mar;21(3):164-183. doi: 10.1038/s41575-023-00867-z. Epub 2023 Dec 8.
10
The Potential of Bile Acids as Biomarkers for Metabolic Disorders.
Int J Mol Sci. 2023 Jul 28;24(15):12123. doi: 10.3390/ijms241512123.

本文引用的文献

1
Chronic fibrosing cholangiopathies: a consequence of a defective HCO₃⁻ "umbrella"?
Clin Res Hepatol Gastroenterol. 2011 Feb;35(2):85-8. doi: 10.1016/j.clinre.2010.10.005.
2
Immediate neuroendocrine signaling after partial hepatectomy through acute portal hyperpressure and cholestasis.
J Hepatol. 2011 Mar;54(3):481-8. doi: 10.1016/j.jhep.2010.07.012. Epub 2010 Sep 22.
3
Mutational characterization of the bile acid receptor TGR5 in primary sclerosing cholangitis.
PLoS One. 2010 Aug 25;5(8):e12403. doi: 10.1371/journal.pone.0012403.
4
Functional characterization of the semisynthetic bile acid derivative INT-767, a dual farnesoid X receptor and TGR5 agonist.
Mol Pharmacol. 2010 Oct;78(4):617-30. doi: 10.1124/mol.110.064501. Epub 2010 Jul 14.
6
Synthesis and structure-activity relationships of a series of 3-aryl-4-isoxazolecarboxamides as a new class of TGR5 agonists.
Bioorg Med Chem Lett. 2010 Feb 15;20(4):1363-7. doi: 10.1016/j.bmcl.2010.01.003. Epub 2010 Jan 7.
7
Bile acid-activated receptors in the treatment of dyslipidemia and related disorders.
Prog Lipid Res. 2010 Apr;49(2):171-85. doi: 10.1016/j.plipres.2009.11.001. Epub 2009 Dec 2.
8
Bile-acid-activated receptors: targeting TGR5 and farnesoid-X-receptor in lipid and glucose disorders.
Trends Pharmacol Sci. 2009 Nov;30(11):570-80. doi: 10.1016/j.tips.2009.08.001. Epub 2009 Sep 14.
9
TGR5-mediated bile acid sensing controls glucose homeostasis.
Cell Metab. 2009 Sep;10(3):167-77. doi: 10.1016/j.cmet.2009.08.001.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验